Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
raffaella.buzzetti@uniroma1.it
Raffaella Buzzetti
Professore Ordinario
Struttura:
DIPARTIMENTO DI MEDICINA SPERIMENTALE
E-mail:
raffaella.buzzetti@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
IFN-α neutralizing antibodies distinguish LADA from early-onset type 1 diabetes
THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
2025
Saxagliptin/dapagliflozin is non‐inferior to insulin glargine in terms of β‐cell function in subjects with latent autoimmune diabetes in adults: A 12‐month, randomized, comparator‐controlled pilot study
DIABETES, OBESITY AND METABOLISM
2024
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk
THE LANCET REGIONAL HEALTH. EUROPE
2024
IDegLira for the real-world treatment of type 2 diabetes in Italy. Final results from the REX observational study
DIABETES, OBESITY AND METABOLISM
2024
Immune checkpoint modulators in early clinical development for the treatment of type 1 diabetes
EXPERT OPINION ON INVESTIGATIONAL DRUGS
2024
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk
THE LANCET REGIONAL HEALTH. EUROPE
2024
LADA 30th anniversary: A growing form of diabetes with persistent unresolved questions
DIABETES/METABOLISM RESEARCH AND REVIEWS
2024
No differences in kidney function decline between people with type 2 diabetes starting a sodium-glucose cotransporter 2 inhibitor or a glucagon-like peptide-1 receptor agonist: a real-world retrospective comparative observational study
CLINICAL THERAPEUTICS
2024
Open questions on basal insulin therapy in T2D: a Delphi consensus
ACTA DIABETOLOGICA
2024
Improved HbA1c and body weight in GADA-positive individuals treated with tirzepatide: A post hoc analysis of SURPASS
THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
2024
Correction: An updated algorithm for an effective choice of continuous glucose monitoring for people with insulin-treated diabetes
ENDOCRINE
2024
Deterioration of Vestibular Motion Perception: A Risk Factor for Postural Instability and Falls in Elderly With Type 2 Diabetes
DIABETES/METABOLISM RESEARCH AND REVIEWS
2024
Type 2 diabetes in children and adolescents: Challenges for treatment and potential solutions
DIABETES RESEARCH AND CLINICAL PRACTICE
2024
Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes
DIABETES/METABOLISM RESEARCH AND REVIEWS
2023
Impact of baseline kidney function on the effects of sodium-glucose co-transporter-2 inhibitors on kidney and heart failure outcomes: A systematic review and meta-analysis of randomized controlled trials
DIABETES, OBESITY AND METABOLISM
2023
Sex Differences in Cardiovascular Disease and Cardiovascular Risk Estimation in Patients With Type 1 Diabetes
THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
2023
Short-term effectiveness of dapagliflozin versus {DPP}-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
2023
Lack of Association between Serum Chitotriosidase Activity and Arterial Stiffness in Type 2 Diabetes without Cardiovascular Complications
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2023
Glycated haemoglobin in the first year after diagnosis of type 1 diabetes is an independent risk factor for diabetic retinopathy: The IMDIAB 25 years follow-up study
DIABETES, OBESITY AND METABOLISM
2023
Validation in type 2 diabetes of a metabolomic signature of all-cause mortality
DIABETES/METABOLISM RESEARCH AND REVIEWS
2023
1
2
3
4
5
6
7
8
seguente ›
ultima »
Progetti di Ricerca
Slowly progressive autoimmune diabetes: a clinical model for novel pathways of ß-cell protection
Nuovi marcatori di malattia vascolare nel diabete mellito: ruolo svolto da sclerostina, RUNX2 ed osteopontina nel meccanismo aterosclerotico.
Genetics and autoantibody heterogeneity of autoimmune diabetes: implications for precision medicine
Gruppi di ricerca - Responsabile
Intervento farmacologico inibente la differenziazione delle cellule mieloidi verso un fenotipo calcificante
Slowly progressive autoimmune diabetes: a clinical model for novel pathways of ß-cell protection
Molecular and pathophysiological heterogeneity of autoimmune diabetes: implications for precision medicine
Synergies anchoring to gravity (SynErg): a novel test to diagnose risk of falls in type 2 diabetes patients
Laboratori di ricerca
Diabetologia e Malattie Metaboliche
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma